Acadia Pharmaceuticals said on Monday its experimental drug to treat negative symptoms of schizophrenia failed to meet the main goal in a late-stage study.
https://finance.yahoo.com/news/acadia-pharmaceuticals-schizophrenia-drug-fails-201310896.html
Acadia Pharmaceuticals said on Monday its experimental drug to treat negative symptoms of schizophrenia failed to meet the main goal in a late-stage study.
https://finance.yahoo.com/news/acadia-pharmaceuticals-schizophrenia-drug-fails-201310896.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.